A daily pill from drugmaker Eli Lilly has shown safety results comparable to the leading injectable GLP-1 drugs Mounjaro and ...

A pill from Eli Lilly helped patients improve their blood sugar and shed weight, results that could propel the ...

The results bring Eli Lilly’s pill orforglipron one step closer to becoming a new, needle-free alternative in the booming ...

Researchers found that by December 2023, more than 1 in 3 of the medications being started for type 2 diabetes treatment were GLP-1RA-based medications.

This makes them a high source of protein for people with diabetes. Eggs are a suitable food for people with diabetes. Having a low glycemic index score means that they have less of an effect on a ...

The product is packaged in an emergency kit and is indicated for the treatment of severe hypoglycemia in patients with type 1 diabetes. It is less costly than brand name versions but is just as safe ...

Ways to lower your blood sugar quickly include injecting insulin, taking a missed diabetes medication, exercising, and more. When you have type 1 or type 2 diabetes, dangerous spikes in blood glucose ...

Researchers found evidence for reduced risk of dying from all causes and cardiovascular disease when OSA patients were treated ... can lead to hypertension, diabetes, cardiovascular disease ...

Data were collected via a regional digital questionnaire distributed to adults with diabetes using the Danish National Patient Registry. The survey included 7743 individuals with diabetes ...

Diabetes can affect any part of the digestive system. Over time, persistently high blood sugar levels can lead to damage that results in a range of symptoms, including diarrhea in some cases. It ...

High cholesterol has also been tied to diabetes and high blood pressure. In all cases, the underlying cause is that high cholesterol leads to fatty plaques that build up in arteries all over your ...

Data showed no outcome differences based on diabetes status or type of GLP-1 ... in the very low incidence of these events” in patients on GLP-1 receptor agonists. “Although these findings ...